Outer hair cells in the mammalian cochlea receive a cholinergic efferent innervation that constitutes the effector arm of a sound-evoked negative feedback loop. The well-studied suppressive effects of acetylcholine (ACh) release from efferent terminals are mediated by 9/ 10 ACh receptors and are potently blocked by strychnine. Here, we report a novel, efferentmediated enhancement of cochlear sound-evoked neural responses and otoacoustic emissions in mice. In controls, a slow enhancement of response amplitude to supranormal levels appears after recovery from the classic suppressive effects seen during a 70-sec epoch of efferent shocks. The magnitude of post-shock enhancement can be as great as 10 dB, and tends to be greater for highfrequency acoustic stimuli. Systemic strychnine at 10 mg/kg eliminates efferent-induced suppression, revealing a purely enhancing effect of efferent shocks, which peaks within 5 sec after efferent-stimulation onset, maintains a constant level through the stimulation epoch and then slowly decays back to baseline with a time constant of ~100 seconds. In mice with targeted deletion of the 9 ACh receptor subunit, efferent-evoked effects resemble those in wildtypes with strychnine blockade, further showing that this novel efferent effect is fundamentally different from all cholinergic effects previously reported.
Introduction
The cochlea's efferent pathway includes a population of cholinergic cells, the medial olivocochlear (MOC) neurons, which project to outer hair cells (OHCs). It has been known for 50 years that, when activated by shocks, MOC neurons suppress cochlear responses (Galambos 1956 ) by decreasing the normal contribution of OHCs to amplification of cochlear mechanical vibration (Murugasu and Russell 1996a) . It has also long been known that MOC effects can be mimicked by acetylcholine (ACh) perfusion (Katsuki et al. 1965 ), but with a pharmacological profile differing from classic nicotinic or muscarinic receptors in that strychnine is among the most potent antagonists (Galley et al. 1973 ). More recently it was shown that OHCs express two novel ACh receptor subunits of the nicotinic family, 9 and 10, which display a similar strychnine sensitivity and mediate the ligand-gated Ca 2+ entry that initiates MOC effects (Elgoyhen et al. 1994; Elgoyhen et al. 2001) .
In vivo studies revealed that MOC suppressive effects consist of two components: a "fast" effect, with an onset time constant of ~100 msec that presumably arises by coupling of Ca 2+ entry to activation of nearby SK channels; and a "slow" effect, with onset time constant of ~10 sec, in which ACh-gated Ca 2+ entry putatively evokes a wave of Ca 2+ -induced Ca 2+ release, which in turn may activate an extrasynaptic array of Ca 2+ -activated K channels (Sridhar et al. 1997; Sridhar et al. 1995; Murugasu and Russell 1996b) . When fast effects are antagonized with a variety of cholinergic blockers, slow effects decrease proportionately, suggesting that both are downstream of ACh activation of 9/ 10 receptor complexes.
Previous in vivo studies hinted at the existence of MOC-evoked response enhancements: after long (60-sec) epochs of MOC stimulation, cochlear responses recovering from "slow-effect" suppression sometimes "overshoot" the pre-shocks baseline (see Sridhar et al. 1995, Figure 6 ) to supranormal amplitudes and require >100 sec to return to baseline levels. Similarly, in a study of MOC effects on basilar membrane vibrations, in addition to "fast" and "slow" suppressive effects evoked by MOC shock trains, the authors noted that a 'rebound' period of 'hypersensitivity' was often observed after recovery from slow inhibition (see Cooper and Guinan 2003, Figure 3C ). In the absence of evidence to the contrary, this overshoot/rebound was assumed to be part of the recovery process of slow effects, rather than a separately evocable component of efferent effects on the inner ear.
Here, we show that this MOC-evoked slow enhancement is a robust and repeatable phenomenon in the mouse and present evidence that it represents a fundamentally different phenomenon from the fast and slow suppressive effects of ACh previously described. We show systemic strychnine can completely eliminate MOC-evoked suppression without any diminution of slow enhancement. We also re-analyze MOC-evoked effects in mice with targeted deletion of the 9 nicotinic ACh receptor (Vetter et al. 1999 ) and show a similar phenotype: i.e. loss of suppression with a robust slow enhancement remaining in the most sensitive animals. We consider the possibility that this novel phenomenon reflects non-cholinergic effects of the MOC system and/or the involvement of peripheral targets other than OHCs.
Materials and Methods
Experimental procedures: CBA/CaJ and C57Bl/6 mice were obtained from Jackson Laboratories. Mutant lines were supplied from a variety of different laboratories, as described in previous publications (Maison et al. 2006; Vetter et al. 1999) . Their genetic backgrounds were hybrids between 129 substrains and C57Bl/6. For all experiments, mice were tested at 6-8 wks old. All electrophysiological experiments were conducted in a temperature-controlled soundproof chamber maintained at ~32 °C. DPOAE and CAP Responses: Acoustic stimuli were presented via a custom acoustic assembly consisting of two electrostatic drivers (Tucker Davis Technologies, EC-1) to generate acoustic stimuli and a Knowles miniature microphone (EK3103) to record ear-canal sound pressure. Stimuli were generated, and responses measured, with locked digital I-O boards at 4-Nsec sampling (National Instruments, AO-6052E). For DPOAEs, primary tones f 1 and f 2 with f 2 /f 1 = 1.2 and f 2 level 10 dB < f 1 level were presented continuously and the ear-canal sound pressure waveform was amplified (1000X) and averaged (8 or 25 consecutive waveform traces), and a spectrum was computed (Fast Fourier Transform); the process was repeated 2 or 4 times, the resultant spectra averaged, and 2f 1 -f 2 DPOAE amplitude and surrounding noise floor were extracted, a procedure requiring ~1 or 4 seconds of data acquisition and processing time, respectively. When response averaging was set to 25 traces per spectrum, and 4 spectra per point, the noise floors were from -5 to -10 dB SPL, depending on frequency. For CAPs, 5-msec tone pips at 20/sec were presented to the ear canal, and responses from a silver wire on the round window membrane were amplified 10,000X, referred to a ground in the neck muscles, and fed to the I-O for averaging (16 responses averaged per point).
Medial Olivocochlear Assay: Animals were anesthetized with urethane (1.20 g/kg i.p.). A posterior craniotomy and partial cerebellar aspiration were performed to expose the floor of the IV th ventricle. To stimulate the OC bundle, shocks (monophasic pulses of 150 µs duration presented at 200/sec continuously throughout the ~70-sec shock epoch in each run of the MOC assay) were applied through fine silver wires (0.4 mm spacing) placed along the midline, spanning the OC decussation. Shock threshold for facial twitches was determined, muscle paralysis induced with -d-tubocurarine (1.25 mg/kg i.p.), and the animal connected to a respirator via a tracheal cannula. Shock levels were raised to 6 dB above twitch threshold. During the OC suppression assay, f 2 level was typically set to produce a DPOAE 10-15 dB > noise floor. To measure OC effects, repeated measures of baseline DPOAE amplitude were first obtained (n=12), followed by a series of 17 continuous periods in which DPOAE amplitudes were measured with simultaneous shocks to the OC bundle. In some experiments, DPOAE measures and CAP measures were interleaved before during and after the OC shock train.
Results

A. CAPs vs. DPOAEs and the level dependence of MOC effects
Activation of medial olivocochlear (MOC) efferents, which project to the cochlea's outer hair cells (OHCs), can reduce the magnitude of compound action potentials (CAPs), the summed activity of cochlear nerve fibers evoked by short tone pips. MOC activation can also reduce distortion product otoacoustic emissions (DPOAEs: Puria et al. 1996) , which arise when two simultaneously presented tones interact with nonlinearities in mechanoelectric transduction and produce distortions in the receptor potential that drive somatic motility in OHCs (Lukashkin et al. 2002) . These amplified distortions propagate back through the middle ear, where they produce DPOAEs in the ear canal.
In mouse, MOC activation elicits suppression of both CAPs and DPOAEs (Fig. 1A,B) , on both the slow and fast time scales reported in guinea pig (Sridhar et al. 1995) . At low sound pressures, cochlear responses are suppressed "immediately" after onset of MOC activation: the time resolution here is ~6 sec / point, whereas the onset time constant for this "fast effect" is ~100 msec (Wiederhold and Kiang 1970) . The magnitude of fast effect is greater at low stimulus levels for both CAP-and DPOAE-based metrics (Fig. 1C) .
Response suppression can continue to grow for tens of seconds through the roughly 70-80 second shock epoch. This has been called the "slow effect" (Sridhar et al. 1995) . After shock offset, there is an abrupt response rebound (cessation of fast effect), that can be followed by a slower return to baseline, requiring tens of seconds (e.g. 60 and 65 dB traces from Fig, 1A ): another manifestation of the slow suppressive effects of MOC stimulation. According to previous work in guinea pig, these slow effects also appear largest at lower stimulus levels (Sridhar et al., 1995) .
In mouse, both CAPs and DPOAEs show a prominent "overshoot" during the post-shock recovery (Fig. 1A,B) . This response enhancement peaks 75-150 sec after shock cessation and can require hundreds of seconds to return to baseline. Enhancement tends to be larger at lower stimulus levels and is of similar magnitude whether measured via CAPs or DPOAEs (Fig. 1C) . In the work that follows, we show only DPOAE data elicited by stimuli at lower sound pressure levels, i.e. with primary tone levels producing a response 10-15 dB above the measurement noise floor (typically corresponding to primary levels of 25-35 dB SPL).
At higher stimulus levels (60-70 dB SPL), MOC "fast effects" on DPOAEs can invert from suppression to enhancement (Siegel and Kim 1982) , because of the non-monotonicity, or "notch", in DPOAE amplitude vs. level functions (Fig. 2B ) (Lukashkin and Russell 2002) . If MOC fast effects are functionally similar to decreasing the stimulus level, then during MOC shocks, DPOAE suppression should be seen where the level-function slope is positive, and enhancement where the slope is negative. This is the pattern observed for the during-shocks effects in our MOC assay (Fig. 2) . During-shocks suppression was seen for all primary levels, except at the notch (65 dB SPL), where the during-shocks effect inverted to enhancement. In contrast, the post-shocks effect remained an enhancement at all primary levels, suggesting that the two phenomena derive from different mechanisms.
B. Frequency-and threshold-dependence of suppression vs. enhancement
In mammalian ears, fast-onset suppression tends to be largest for frequencies corresponding to the upper basal turn (Guinan and Gifford 1988): in mouse that translates to the 16-22 kHz region (Figs. 3 A, B, C and Fig. 4 ). This frequency distribution fits roughly with the density of cholinergic efferent terminals on OHCs, which also peaks in mid-cochlear regions and falls off at more apical and basal cochlear regions (Maison et al. 2003) .
"Slow-effect" suppression is difficult to quantify in mouse. Indeed, neither the slow, duringshocks increase in suppression nor the lingering post-shocks suppression (visible in the 60 and 65 dB traces from Fig. 1 ) is seen in the mean data (Figs. 3A,B,C). Rather, mean suppression decays during the shock train; and, on average, the 1 st post-shocks data point is above baseline. Slow suppressive effects are visible in individual runs, when the post-shock enhancement is small (Fig. 5C ). The prominence of the during-shocks decay in suppression and the immediate post-shocks jump to large response enhancements (e.g. Fig. 5B ) suggest that the enhancement process might be initiated soon after shock-train onset and is growing during the shock epoch. This view is supported by the correlation between during-shocks decay of suppression and postshocks enhancement ( Fig. 5A ) and by additional results presented below.
Enhancement magnitudes are not closely tied to those of fast-onset suppression (Figs. 3A,B,C). Indeed, at 8 kHz, the mean data shows a subtle but significant enhancement (both during and after the shocks) with virtually no fast suppression (Fig. 3A) . Furthermore, fast suppression at 16 kHz ( Fig. 3B ) has grown re that seen at 8 kHz, whereas enhancement is little changed. In general, slow enhancements tend to increase in magnitude with increasing stimulus frequency (Fig. 4) , unlike the fast suppressive effects.
The magnitudes of both fast suppression and slow enhancement show a weak correlation with cochlear sensitivity (Figs. 3D,E,F), which appears strongest at the highest stimulus frequency (45.2 kHz). Such a correlation is not unexpected for fast suppression, given that 1) this suppression arises when ACh release turns down the contribution of the OHC-based cochlear amplifier to cochlear sensitivity and 2) that most elevations of baseline cochlear thresholds, whether chronic or acute, also arise from loss of OHC "gain" (Patuzzi et al. 1989 ). However, we assume that much of the variation in suppression strength arises from differences in the effectiveness of the electrical stimulation in activating all MOC fibers.
C. Effects of strychnine, LOC destruction or deletion of cholinergic or GABAergic receptors
Strychnine is among the most potent blockers of MOC fast and slow suppression in vivo (Sridhar et al. 1995) and of ACh-induced currents in hair cells (Fuchs and Murrow 1992; Housley and Ashmore 1991) and oocytes transfected to express 9/ 10 receptor complexes in vitro (Elgoyhen et al. 2001; Weisstaub et al. 2002) . Since it crosses the blood-brain barrier, it also has the advantage of systemic administration.
Here, we show that strychnine completely blocks MOC-evoked suppression without changing post-shock enhancement (Fig. 6A) . Within 5 min after strychnine injection, fast suppression is attenuated and, by 20 min, appears to have been abolished; however, the magnitude and time course of the enhancement appear unchanged. At higher concentrations, the slow enhancement is also blocked by strychnine ( Fig 6B) ; however, there is a 20-fold difference in the EC 50 for strychnine block of suppression (0.75 mg/ml) vs. enhancement (15 mg/ml).
As a further test of the independence of fast suppression and slow enhancement, we reevaluated MOC-evoked effects in a mouse with targeted deletion of the 9 cholinergic receptor, previously shown to lack MOC-mediated suppression (Vetter et al. 1999) . Recognizing that large enhancements are not always seen in control ears and that they tend to be largest in ears with good threshold sensitivity (Figs. 3E,F) , we studied a number of 9-null ears. We found a robust MOC-mediated enhancement in those ears with the best sensitivity ( Fig. 6C) : its magnitude and time course were remarkably similar to that seen in control ears following strychnine treatment (Fig. 6A) . Similar results, i.e. a slow enhancement of cochlear responses with no sign of fast or slow suppression, were seen in mice with targeted deletion of the 10 nicotinic ACh receptor (Vetter et al. 2005a ) and in mice lacking the SK2 channel (Vetter et al. 2005b) .
To better reveal the onset time constant of the enhancement effect, DPOAE averaging time was reduced to ~ 1 sec/ point. Based on these more densely sampled DPOAE measures obtained from the 9-null ears, we estimate the onset time constant to be ~ 2 sec.
To rule out the possibility that the slow post-shocks enhancement seen in wildtype ears is due to LOC activation rather than the MOC system, we re-examined data from a study in which the LOC was selectively destroyed by stereotaxic injection of neurotoxin (Darrow et al. 2006 ) and found clear examples of the enhancement phenomenon is ears with histologically verified lesions to the LOC cells of origin: one example is shown in Fig. 7B .
There is evidence for muscarinic ACh receptors in OHCs (Safieddine et al. 1996) in addition to the nicotinic subunits 9 and 10. In an ongoing study of cochlear phenotype in mouse lines with targeted deletion of each of the five muscarinic receptor subtypes, M1 -M5 (Maison et al. 2007b) , cochlear response to MOC shocks was investigated: slow, post-shocks enhancement was demonstrable in each of the five mutant lines (data not shown).
MOC terminals in mouse also express markers of GABAergic transmission (Maison et al. 2003) . To examine whether GABAergic effects are involved in generation of the slow enhancement, we evaluated MOC-evoked effects in a number of mouse lines with targeted deletion of different GABA A receptor subunits (Maison et al. 2006) . That evaluation failed to reveal one in which post-shocks enhancement were eliminated (Fig. 7A) . Similarly, post-shocks enhancement is robust in mice without GABA B receptor signaling (data not shown), due to deletion of the gene for the B(1) subunit, a compulsory component of functional GABA B receptors (Maison et al. 2007a ).
Discussion
A. 9-mediated effects vs. 9-independent effects on hair cells and cochlear responses
The suppression of cochlear responses in vivo by stimulation of a cholinergic feedback pathway was first described 50 years ago (Galambos 1956) . Cochlear suppressive effects could be mimicked by ACh perfusion (Galley et al. 1973) , but with an atypical pharmacology characterized by strychnine blockade (Bobbin and Konishi 1974) . In vitro work suggested that ACh-induced hyperpolarization and conductance increase arise from coupling strychnine sensitive Ca 2+ -entry through a cholinergic receptor to Ca 2+ activation of an apamin-sensitive, small-conductance K + channel (Fuchs and Murrow 1992) identified as the SK2 channel (Dulon, et al., 1998) . A search for novel ACh receptors revealed, first, the 9 and subsequently the 10 subunits, both expressed in OHCs (Elgoyhen et al. 1994; Elgoyhen et al. 2001 ). Both 9 homomers and 9/ 10 heteromers were shown to be extremely strychnine-sensitive, with IC 50 of ~20 nM, and targeted deletion of the 9 subunit eliminated OC-mediated cochlear suppression (Vetter et al. 1999) , consistent with the report that expression of 10 by itself does not yield any detectable ACh currents (Elgoyhen et al. 2001) .
Later in vivo studies revealed that MOC activation evokes both a fast suppression of cochlear CAP, with onset time constant of ~100 msec, and a slower suppression with an onset time constant of ~10 sec (Sridhar et al. 1995) . The mechanical counterparts of fast and slow suppression were also measured in basilar membrane motion (Cooper and Guinan 2003) . Pharmacological studies suggested that both fast and slow suppression require ACh binding with an 9 receptor complex, followed by two distinct downstream effects of Ca 2+ entry: 1) activation of an SK channel to give rise to the fast effect and 2) a wave of Ca 2+ -induced Ca 2+ release to evoke the slow effect (Sridhar et al. 1995; 1997; Murugasu and Russell 1996b) . The fact that both fast and slow suppression involve changes in cochlear microphonics, the summed receptor potentials of OHCs, suggested that both produce changes in OHC K + conductance (Sridhar et al. 1995) . Pharmacological evidence suggested that the putative slow-effect Ca Previous studies of cochlear CAP or basilar membrane motion noted that MOC shocks sometimes elicited a slow-onset, slow-offset "overshoot" characterized by supra-normal response amplitudes in the post-shocks recovery to baseline (Cooper and Guinan 2003; Sridhar et al. 1995) . However, it was assumed that this overshoot was part of the recovery from slow suppression. Since recovery from overshoot could be extremely slow, the phenomenon was difficult to study and was not systematically pursued. Here, we show, with strychnine administration or 9 deletion, that the "overshoot" can be dissected from both fast and slow suppression, and thus must represent a separate, distinct and 9-independent effect of efferent stimulation. The onset time constant of this novel slow enhancement appears to be ~2 sec, it tends to saturate after ~5 sec of continued MOC activation, and its offset time constant is ~100 sec. Previous study of 9-null mice failed to see the slow enhancement (Vetter et al. 1999) , because a different OC stimulation paradigm was used (6-second shock trains were interleaved with 6-second control periods), which fails to evoke robust enhancements even in control mice (data not shown).
The discovery of a third robust and independent efferent effect on cochlear responses raises questions about the correspondence between in vivo and in vitro observations. It still seems safe to assume that the Ca 2+ -activated K + conductance observed in vitro contributes to the fast suppressive effect observed in vivo. There has been no clear-cut dissection of fast and slow suppressive effects in the in vitro work with ACh-induced hair cell currents; thus, there is also no clear in vitro correlate to be proposed for slow enhancement. However, in addition to conductance changes in isolated hair cells, ACh-induced increases in OHC electromotility have also been documented (Sziklai et al. 1996) , which may involve Ca 2+ -activated modification of cytoskeletal elements via intracellular GTPases (Zhang et al. 2003) . The previous assumption that ACh-induced increase in OHC electromotility in vitro is intimately related to the slow suppression observed in vivo (Cooper and Guinan, 2003) needs to be re-examined. Although the electromotility changes are strychnine sensitive (Dallos et al. 1997 ), we show here (Fig. 6 ) that both 9-mediated (suppressive) and non-9-mediated (enhancing) in vivo effects are strychnine sensitive, albeit with a 20-fold difference in IC 50 .
B. Mechanisms underlying the slow enhancement 1) Ruling out non-MOC effects
Although electrical stimulation of the OC bundle at the floor of the IV th ventricle activates MOC fibers projecting to OHCs, there are other efferent pathways to the auditory periphery that could be activated by electrodes at this location and whose potential contribution to the novel shock-evoked effect must be considered.
Contribution of the lateral (L) component of the OC system is unlikely, because the lack of myelination of LOC fibers at the electrode site make them hard to stimulate (Groff and Liberman 2003) , and because their peripheral targets are exclusively in the IHC area where it is hard to imagine eliciting an effect on DPOAEs (Liberman et al. 1997 ). Furthermore, we have shown that LOC destruction does not eliminate slow, post-shocks enhancement in wildtype ears (Fig. 7B) .
Contribution of the middle-ear muscles is also unlikely, given that activation of these pathways should only depress cochlear responses (Nuttall 1974), and we routinely paralyze our animals with curare, which eliminates all facial twitches otherwise elicited by the brainstem shocks (See also (Rajan 1991)). Middle-ear muscle activation increases the impedance of the ossicular chain and alters sound pressure in the ear canal, forming the basis for the non-invasive clinical test of middle-ear muscle function (Counter et al. 1989 ) and allowing us to evaluate individual runs of our assay for signs of middle-ear muscle contraction. Large post-shocks enhancements can routinely be seen without any significant changes in primary tone sound pressure, thus ruling out both middle-ear muscles and other conceivable changes in ear-canal musculature that might alter sound transmission through the external and middle ears.
The cochlea's sympathetic innervation arises from both the stellate and the superior cervical ganglia, giving rise, respectively, to a vascular innervation and a projection to the dendrites of cochlear afferents neurons as they exit the organ of Corti (Hultcrantz et al. 1982; Ren et al. 1993) . Although both these ganglia are too distant from the electrode site to be directly stimulated, more indirect pathways are conceivable. Direct sympathetic effects on cochlear nerve fibers are poorly understood; however, it is difficult to imagine how a post-synaptic effect on the cochlea's afferent neurons outside the organ of Corti could affect the DPOAE, which is known to be unaffected by loss of IHCs and/or cochlear afferents contacting them (Liberman et al. 1997) . Depressing the resting level of stellate ganglion's (vasoconstrictor) activity could theoretically enhance cochlear responses, given that cutting its peripheral projections can increase cochlear blood flow up to 25% (Laurikainen et al. 1997) ; however, existing literature suggests that changes in cochlear responses such as CAP are not associated with these relatively modest blood flow enhancements.
2) Possible MOC effects
Assuming that the shock-evoked response enhancement is MOC mediated and given that it is not mediated by ACh binding to 9 receptors on OHCs, a number of different transmitters, receptors and/or MOC targets remain as possible players in the phenomenon.
With respect to other ACh receptors in OHCs, RT-PCR and in situ hybridization fail to reveal additional nAChRs besides 9/ 10 (Morley et al. 1998). Furthermore, no ACh-induced ionic currents are measurable in isolated hair cells after strychnine blockade (Verbitsky et al. 2000) . However, effects of metabotropic-receptor activation would not be detected in such experiments, and there is evidence for muscarinic (m)ACh receptors in the ear: 1) RT-PCR in mouse cochleas suggest expression of M1, M3 and M5 mAChRs transcripts (Drescher et al. 1992) , and 2) in situ hybridization suggest M3 expression in the OHC area (except in the apical turn), the IHC area and spiral ganglion neurons (Safieddine et al. 1996) . Although there is evidence for muscarinic signaling in type-I ganglion cells (innervating inner hair cells), such a post-synaptic effect should not alter DPOAEs, given that this OHC-based response is unaffected by total loss of type-I responses (Liberman et al. 1997 ). On the other hand, muscarinic effects on OHCs must be considered: ACh-induced cochlear upregulation of the phosphoinositide second messenger system has been reported in guinea pig with a muscarinic pharmacological profile (Niedzielzki et al. 1992) . However, such putative muscarinic effects should not be sensitive to strychnine blockade (Fig. 6) ; and more definitively, our own recent work on mouse lines with targeted deletion of each of the five muscarinic receptor subtypes failed to identify one in which enhancements cannot be evoked by MOC stimulation.
In mouse, MOC terminals in the OHC area co-localize ACh and GABA (Maison et al. 2003 ), thus GABAergic effects on OHCs must be considered. There is immunohistochemical evidence for (ionotropic) GABA A receptors on OHCs and/or ganglion cells, and strong phenotypes following targeted deletion suggest a cochlear role for 5, 2 and 3 subunits (Maison et al. 2006) . Although GABA application affects OHC motility and stiffness in vitro (Batta et al. 2004; Sziklai et al. 1996) , such effects are only seen in low-frequency cells, which does not match the high-frequency bias of slow enhancement (Fig. 4) . Furthermore, we showed here that deletion of 5 different GABA A subunits did not eliminate the slow enhancement phenomenon (Fig. 7) . Not all subunits were assayed in this study, thus a role for GABA A signaling cannot be conclusively ruled out. However, a role for (metabotropic) GABA B signaling can be safely eliminated by the demonstration that slow enhancement can still be evoked in mice with targeted deletion of the gene for the B(1) subunit, a compulsory component of functional GABA B receptors (Haller et al. 2004) .
The complex synaptic circuitry in the OHC area (Fig. 8) suggests a number of additional pathways by which MOC activation could affect cochlear responses. Although large MOC synapses at the bases of OHCs are most prominent, MOC efferents also synapse along the sides of OHCs, and it is claimed that these supranuclear terminals have a distinct cytochemistry (Altschuler et al. 1984) . However, the spiral gradient of supranuclear terminals (increasing numbers towards the low-frequency end (Liberman 1990)) is opposite to that seen for slow enhancement (Fig. 4) . MOC terminals also form synapses with type-II "afferent" neurons, either at their cell body (Thiers et al. 2000) , or on their terminals under the OHCs (Thiers et al. 2002) ; and type-II "afferents", in turn, synapse with supporting cells (Fechner et al. 2001 ) that form the "flying buttress" at the outer border of the reticular lamina (Fig. 8) . ACh-induced changes in supporting cell Ca 2+ influx have been reported (Matsunobu et al. 2001) ; thus, MOC activation could change DPOAEs and CAPs via cholinergic effects on cochlear mechanics that involve no change in OHC function per se. However, the apex-to-base gradient of these supporting cell synapses (Fechner et al. 1999 ) is also opposite to that of the slow-enhancement.
The final potential pathway arises from the discovery that synapses of type-II neurons with OHCs appear to be reciprocal in nature (Nadol 1981), i.e. signals are transmitted in both directions. If true, MOC activation could affect OHCs indirectly via MOC synapses on type-II terminals under the OHCs and the reciprocal synapses of type-II terminals with OHCs. Interestingly, the apex-base gradient of type-II innervation to OHCs in mouse appears to mirror that of the slow enhancement (Liberman, unpublished) . The nature of the transmitter and receptors involved at the putative efferent component of the type-II/OHC synapse is completely unknown. However, cochlear ganglion cells express a number of nAChRs (Bao et al. 2005) , notably 2, 4 and 7 (Morley et al. 1998) . In hippocampus, homomeric nAChRs containing 7 subunits, or heteromeric receptors containing 4 2 subunits can be blocked by strychnine (Matsubayashi et al. 1998) , though with a higher IC 50 than reported for 9/ 10 blockade. Thus, either of these pentameric receptor complexes could be present at the MOC/type-II synapses and thus represent an interesting candidate link in the slow-enhancement phenomenon reported here. 
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